Signaling pathways
-
BA2699 MC-Val-Cit-PAB-RetapamulinSummary: Part of an antibody-coupled active molecule consisting of the protein synthesis inhibitor Retapamulin linked to MC-Val-Cit-PAB. - BA2700 MC-Val-Cit-PAB-rifabutinSummary: MC-Val-Cit-PAB-rifabutin is part of an antibody-coupled active molecule.
- BA2701 NHS-MMAFSummary: NHS-MMAF is a modified MMAF.
- BA2702 PSMA-Val-Cit-PAB-MMAESummary: PSMA-Val-Cit-PAB-MMAE is a novel small molecule PSMA-targeting conjugate based on MMAE.
- BA2703 DL-01Summary: DL-01 is an ADC active molecule-linker coupling.
- BA2704 SC-VC-PAB-DM1Summary: SC-VC-PAB-DM1 is part of an antibody-coupled reactive molecule with anticancer activity.
- BA2705 Azido-PEG4-Val-Cit-PAB-MMAESummary: Azido-PEG4-Val-Cit-PAB-MMAE is part of an antibody coupled active molecule (drug-linkerconjugateforADC).
- BA2706 MC-Val-Cit-PAB-clindamycinSummary: MC-Val-Cit-PAB-clindamycin is part of an antibody-coupled active molecule.
- BA2707 MC-Gly-Gly-Phe-Gly-GABA-ExatecanSummary: MC-Gly-Gly-Phe-Gly-GABA-ExatecanADC is a drug-linker coupler containing 22 μM topoisomerase.
- BA2708 Cyclooctyne-O-amido-PEG4-VC-PAB-Gly-Gly-NH-O-CO-ExatecanSummary: Cyclooctyne-O-amido-PEG4-VC-PAB-Gly-Gly-NH-O-CO-Exatecan be used as a drug-linker coupler for ADC.